Magic Medicine

The National Medical Products Administration (NMPA) has granted marketing approval to Shanghai Magic Medicine’s multimodal tumor treatment system, marking it as the 209th novel device approved in China. This approval signifies a significant advancement in the field of oncology treatment options within the country. Integrating Liquid Nitrogen Freezing and Radio…